Molecular	O
insights	O
into	O
the	O
inhibitory	O
mechanism	O
of	O
rifamycin	B:C0073371
SV	I:C0073371
against	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
aggregation	O
:	O
A	O
molecular	O
dynamics	O
simulation	O
study	O
.	O

Molecular	O
insights	O
into	O
the	O
inhibitory	O
mechanism	O
of	O
rifamycin	O
SV	I:C0073371
against	O
β	B:C0005149
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
aggregation	O
:	O
A	O
molecular	O
dynamics	O
simulation	O
study	O
.	O

Molecular	O
insights	O
into	O
the	O
inhibitory	O
mechanism	O
of	O
rifamycin	O
SV	I:C0073371
against	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
aggregation	B:C3850147
:	O
A	O
molecular	O
dynamics	O
simulation	O
study	O
.	O

Dialysis	B:C3266969
-	I:C3266969
related	I:C3266969
amyloidosis	O
(	O
Dialysis	O
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	O
joints	O
and	O
bones	O
.	O

Dialysis	O
-	I:C3266969
related	I:C3266969
amyloidosis	B:C0002726
(	O
Dialysis	O
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	O
joints	O
and	O
bones	O
.	O

Dialysis	O
-	I:C3266969
related	I:C3266969
amyloidosis	O
(	O
Dialysis	B:C0002726
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	O
joints	O
and	O
bones	O
.	O

Dialysis	O
-	I:C3266969
related	I:C3266969
amyloidosis	O
(	O
Dialysis	O
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	B:C1456454
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	O
joints	O
and	O
bones	O
.	O

Dialysis	O
-	I:C3266969
related	I:C3266969
amyloidosis	O
(	O
Dialysis	O
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	O
β	B:C0005149
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	O
joints	O
and	O
bones	O
.	O

Dialysis	O
-	I:C3266969
related	I:C3266969
amyloidosis	O
(	O
Dialysis	O
-	I:C0002726
related	I:C0002726
amyloidosis	I:C0002726
)	O
is	O
a	O
severe	O
condition	O
characterized	O
by	O
the	O
accumulation	O
of	O
amyloidogenic	O
β	O
2	I:C0005149
-	I:C0005149
microglobulin	I:C0005149
(	I:C0005149
β	I:C0005149
2	I:C0005149
m	I:C0005149
)	I:C0005149
protein	I:C0005149
around	O
skeletal	B:C0521324
joints	O
and	O
bones	O
.	O

The	O
small	O
molecules	O
that	O
modulate	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
aggregation	O
have	O
been	O
identified	O
in	O
vitro	O
,	O
however	O
,	O
the	O
underlying	O
inhibitory	O
mechanism	O
remain	O
elusive	O
.	O

The	O
small	O
molecules	O
that	O
modulate	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	B:C3850147
have	O
been	O
identified	O
in	O
vitro	O
,	O
however	O
,	O
the	O
underlying	O
inhibitory	O
mechanism	O
remain	O
elusive	O
.	O

In	O
the	O
present	O
study	O
,	O
molecular	B:C3494273
docking	I:C3494273
and	O
molecular	O
dynamics	O
(	O
MD	O
)	O
simulations	O
were	O
performed	O
to	O
elucidate	O
the	O
inhibitory	O
mechanism	O
of	O
an	O
antibiotic	O
,	O
rifamycin	O
SV	I:C0073371
(	O
C1	O
)	O
reported	O
for	O
its	O
in	O
vitro	O
anti-aggregation	O
activity	O
against	O
β	O
2	I:C0005149
m	I:C0005149
.	O

In	O
the	O
present	O
study	O
,	O
molecular	O
docking	I:C3494273
and	O
molecular	O
dynamics	O
(	O
MD	O
)	O
simulations	O
were	O
performed	O
to	O
elucidate	O
the	O
inhibitory	O
mechanism	O
of	O
an	O
antibiotic	B:C0003232
,	O
rifamycin	O
SV	I:C0073371
(	O
C1	O
)	O
reported	O
for	O
its	O
in	O
vitro	O
anti-aggregation	O
activity	O
against	O
β	O
2	I:C0005149
m	I:C0005149
.	O

In	O
the	O
present	O
study	O
,	O
molecular	O
docking	I:C3494273
and	O
molecular	O
dynamics	O
(	O
MD	O
)	O
simulations	O
were	O
performed	O
to	O
elucidate	O
the	O
inhibitory	O
mechanism	O
of	O
an	O
antibiotic	O
,	O
rifamycin	B:C0073371
SV	I:C0073371
(	O
C1	O
)	O
reported	O
for	O
its	O
in	O
vitro	O
anti-aggregation	O
activity	O
against	O
β	O
2	I:C0005149
m	I:C0005149
.	O

In	O
the	O
present	O
study	O
,	O
molecular	O
docking	I:C3494273
and	O
molecular	O
dynamics	O
(	O
MD	O
)	O
simulations	O
were	O
performed	O
to	O
elucidate	O
the	O
inhibitory	O
mechanism	O
of	O
an	O
antibiotic	O
,	O
rifamycin	O
SV	I:C0073371
(	O
C1	B:C0073371
)	O
reported	O
for	O
its	O
in	O
vitro	O
anti-aggregation	O
activity	O
against	O
β	O
2	I:C0005149
m	I:C0005149
.	O

In	O
the	O
present	O
study	O
,	O
molecular	O
docking	I:C3494273
and	O
molecular	O
dynamics	O
(	O
MD	O
)	O
simulations	O
were	O
performed	O
to	O
elucidate	O
the	O
inhibitory	O
mechanism	O
of	O
an	O
antibiotic	O
,	O
rifamycin	O
SV	I:C0073371
(	O
C1	O
)	O
reported	O
for	O
its	O
in	O
vitro	O
anti-aggregation	O
activity	O
against	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
.	O

The	O
molecular	B:C3494273
docking	I:C3494273
analysis	I:C3494273
highlight	O
that	O
C1	O
display	O
hydrophobic	O
contacts	I:C0678607
with	O
residues	O
in	O
the	O
aggregation	O
prone	O
region	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

The	O
molecular	O
docking	I:C3494273
analysis	I:C3494273
highlight	O
that	O
C1	B:C0073371
display	O
hydrophobic	O
contacts	I:C0678607
with	O
residues	O
in	O
the	O
aggregation	O
prone	O
region	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

The	O
molecular	O
docking	I:C3494273
analysis	I:C3494273
highlight	O
that	O
C1	O
display	O
hydrophobic	B:C0678607
contacts	I:C0678607
with	O
residues	O
in	O
the	O
aggregation	O
prone	O
region	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

The	O
molecular	O
docking	I:C3494273
analysis	I:C3494273
highlight	O
that	O
C1	O
display	O
hydrophobic	O
contacts	I:C0678607
with	O
residues	O
in	O
the	O
aggregation	B:C3850147
prone	O
region	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

The	O
molecular	O
docking	I:C3494273
analysis	I:C3494273
highlight	O
that	O
C1	O
display	O
hydrophobic	O
contacts	I:C0678607
with	O
residues	O
in	O
the	O
aggregation	O
prone	O
region	O
of	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
.	O

MD	O
simulations	O
reveal	O
enhanced	O
structural	O
stability	O
of	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
in	O
the	O
presence	O
of	O
C1	O
.	O

MD	O
simulations	O
reveal	O
enhanced	O
structural	O
stability	O
of	O
β	O
2	I:C0005149
m	I:C0005149
in	O
the	O
presence	O
of	O
C1	B:C0073371
.	O

C1	B:C0073371
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	B:C0301641
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	B:C1707271
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	B:C0162806
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	B:C0033625
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	B:C3544412
of	O
β	O
2	I:C0005149
m	I:C0005149
.	O

C1	O
inhibit	O
the	O
conformational	O
transition	I:C0301641
of	O
the	O
C-	O
terminal	I:C1707271
region	I:C1707271
of	O
β	O
2	I:C0005149
m	I:C0005149
from	O
a	O
β-	O
sheet	I:C0162806
to	O
random	O
coil	O
conformation	O
,	O
which	O
is	O
reported	O
for	O
the	O
initiation	O
of	O
fibrillogenesis	O
of	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
.	O

The	O
results	O
of	O
the	O
present	O
study	O
provide	O
insight	O
into	O
the	O
key	O
interactions	O
and	O
underlying	O
inhibitory	O
mechanism	O
of	O
a	O
small	O
molecule	O
against	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
aggregation	O
that	O
will	O
help	O
in	O
the	O
design	O
and	O
development	O
of	O
more	O
potent	O
,	O
novel	O
inhibitors	O
of	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
provide	O
insight	O
into	O
the	O
key	O
interactions	O
and	O
underlying	O
inhibitory	O
mechanism	O
of	O
a	O
small	O
molecule	O
against	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	B:C3850147
that	O
will	O
help	O
in	O
the	O
design	O
and	O
development	O
of	O
more	O
potent	O
,	O
novel	O
inhibitors	O
of	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
provide	O
insight	O
into	O
the	O
key	O
interactions	O
and	O
underlying	O
inhibitory	O
mechanism	O
of	O
a	O
small	O
molecule	O
against	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	O
that	O
will	O
help	O
in	O
the	O
design	O
and	O
development	O
of	O
more	O
potent	O
,	O
novel	O
inhibitors	B:C0243077
of	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
provide	O
insight	O
into	O
the	O
key	O
interactions	O
and	O
underlying	O
inhibitory	O
mechanism	O
of	O
a	O
small	O
molecule	O
against	O
β	O
2	I:C0005149
m	I:C0005149
aggregation	O
that	O
will	O
help	O
in	O
the	O
design	O
and	O
development	O
of	O
more	O
potent	O
,	O
novel	O
inhibitors	O
of	O
β	B:C0005149
2	I:C0005149
m	I:C0005149
aggregation	O
.	O

